157 related articles for article (PubMed ID: 32350851)
1. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
Li M; Shen Y; Chen Y; Gao H; Zhou J; Wang Q; Fan C; Zhang W; Li J; Cong H; Gu J; Gan Y; Tu H
Int J Cancer; 2020 Oct; 147(8):2199-2209. PubMed ID: 32350851
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
3. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract][Full Text] [Related]
4. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
[TBL] [Abstract][Full Text] [Related]
5. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
6. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
7. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis.
Nath A; Agarwal R; Malhotra P; Varma S
Intern Med J; 2010 Sep; 40(9):633-41. PubMed ID: 19811561
[TBL] [Abstract][Full Text] [Related]
10. High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance.
Wang F; Yuan S; Teng KY; Garcia-Prieto C; Luo HY; Zeng MS; Rao HL; Xia Y; Jiang WQ; Huang HQ; Xia ZJ; Sun XF; Xu RH
Eur J Cancer Prev; 2012 May; 21(3):261-7. PubMed ID: 22433629
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.
Becker N; Schnitzler P; Boffetta P; Brennan P; Foretova L; Maynadié M; Nieters A; Staines A; Benavente Y; Cocco P; de Sanjose S
J Cancer Res Clin Oncol; 2012 Dec; 138(12):1993-2001. PubMed ID: 22767316
[TBL] [Abstract][Full Text] [Related]
12. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
13. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.
Tamori A; Yamanishi Y; Kawashima S; Kanehisa M; Enomoto M; Tanaka H; Kubo S; Shiomi S; Nishiguchi S
Clin Cancer Res; 2005 Aug; 11(16):5821-6. PubMed ID: 16115921
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
Kim M; Lee YK; Park B; Oh DJ; Choi HG
J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
Loglio A; Viganò M; Grossi G; Labanca S; Goldaniga M; Pompa A; Farina L; Rumi M; Corradini P; Facchetti F; Lunghi G; Baldini L; Lampertico P
Dig Liver Dis; 2019 Mar; 51(3):419-424. PubMed ID: 30316785
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
19. Detection of HBsAg, HBcAg, and HBV DNA in ovarian tissues from patients with HBV infection.
Chen LZ; Fan XG; Gao JM
World J Gastroenterol; 2005 Sep; 11(35):5565-7. PubMed ID: 16222757
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
